CN108358878A - Isoflavones noval chemical compound and its preparation method and application in big fruit banyan - Google Patents

Isoflavones noval chemical compound and its preparation method and application in big fruit banyan Download PDF

Info

Publication number
CN108358878A
CN108358878A CN201810022626.0A CN201810022626A CN108358878A CN 108358878 A CN108358878 A CN 108358878A CN 201810022626 A CN201810022626 A CN 201810022626A CN 108358878 A CN108358878 A CN 108358878A
Authority
CN
China
Prior art keywords
isoflavones
chemical compound
noval chemical
preparation
big fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810022626.0A
Other languages
Chinese (zh)
Other versions
CN108358878B (en
Inventor
韩长日
邵泰明
宋小平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Normal University
Hainan Institute of Science and Technology
Original Assignee
Hainan Normal University
Hainan Institute of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Normal University, Hainan Institute of Science and Technology filed Critical Hainan Normal University
Priority to CN201810022626.0A priority Critical patent/CN108358878B/en
Publication of CN108358878A publication Critical patent/CN108358878A/en
Application granted granted Critical
Publication of CN108358878B publication Critical patent/CN108358878B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40Separation, e.g. from natural material; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of preparation method and applications of isoflavones noval chemical compound in big fruit banyan, preparing for the isoflavones noval chemical compound is as follows:It by big fruit banyan root grinding and sieving, is extracted with alcoholic solution cold soaking, medicinal extract is obtained after reduced pressure, distillation aqueous suspension is added in medicinal extract, extracts to obtain each position medicinal extract with petroleum ether, ethyl acetate successively;Ethyl acetate extract obtains isoflavones noval chemical compound through column chromatography, efficient liquid phase.The isoflavones noval chemical compound that the present invention is extracted from big fruit banyan, which has, preferably inhibits three kinds of tumor cell proliferation effects.

Description

Isoflavones noval chemical compound and its preparation method and application in big fruit banyan
Technical field
The present invention relates to a kind of natural plant extracts, and in particular in a kind of big fruit banyan isoflavones noval chemical compound and its Preparation method and application.
Background technology
Big fruit banyan(Ficus auriculatalour)For Moraceae Ficus(Ficus)Plant, alias steamed bun fruit, fruit taste Sweet tea is edible, is distributed mainly on the torrid zone and subtropical zone, Hainan, Guangxi, Yunnan, Guizhou, Sichuan etc. are mainly distributed in China Ground,《Southern herbal garden plant list》Record big fruit banyan fruit with wind-dispelling facilitaing lung, tonifying kidney and benefiting sperm effect, cure mainly cough with lung heat, seminal emission, It spits blood.Big fruit banyan chemical composition and bioactivity research are shown in big fruit banyan containing the ingredients such as isoflavones in recent years and with compared with Good bioactivity.Qi Cuicui etc.(A new isoflavone from the roots ofFicus auriculata[J]. Natural Product Research, 2018, 32(1):43)Isolated 4 have antibacterial activity from big fruit banyan root Isoflavone compound.Tan Lin etc.(Big fruit banyan fruit ethanol extract antioxidant activity and rightαGlucuroide and acetyl Cholinesterase inhibition [J] Food Sciences, 2016. 37 (13): 77)To polyphenol content in big fruit banyan fruit and its resist Oxidation,αGlucuroide and inhibiting activity of acetylcholinesterase are studied, the results showed that big fruit banyan fruit polyphenol has good Oxidation activity well,αGlucuroide and certain inhibiting activity of acetylcholinesterase.At present still lack big fruit banyan isoflavones at The system research divided, antitumor activity need further to study.
Invention content
Present invention aims at solving the above problems, isoflavones with anti-tumor activity new in a kind of big fruit banyan is provided Noval chemical compound and its preparation method and application.
Realizing the technical solution of the object of the invention is:A kind of isoflavones noval chemical compound, structure such as formula(Ⅰ)It is shown:
(Ⅰ).
The preparation method of above-mentioned isoflavones noval chemical compound includes the following steps:
1. with medicinal extract is obtained after alcoholic solution extraction concentration after big fruit banyan tissue nature is dried in the shade, is crushed, medicinal extract adds distillation aqueous suspension Petroleum ether, ethyl acetate extract is obtained by extraction with petroleum ether, ethyl acetate afterwards;
2. 1. ethyl acetate extract that step obtains is obtained 7 component A-G through silica gel column chromatography, component C is again through petroleum ether-second Acetoacetic ester system gradient elution merges similar fraction and obtains 5 component Fr1-5;
3. 2. Fr3 that step is obtained is through the isolated isoflavones noval chemical compound of efficient liquid phase.
In above-mentioned steps 1. described in big fruit banyan be organized as big fruit banyan root, stem, leaf or fruit, alcoholic solution is that volume fraction is The ethanol solution of 75%-95%, the distilled water are 1 with medicinal extract volume ratio:1.
It is 100 that 2. the agent of center pillar chromatographic elution, which is petroleum ether-ethyl acetate volume ratio, in above-mentioned steps:0-0:100.
Above-mentioned steps 3. described in efficient liquid phase dicyandiamide solution be -55% water of 45% methanol.
Application of the above-mentioned isoflavones noval chemical compound on inhibiting tumour cell, the tumour cell are that cervical cancer Hela cells are thin Born of the same parents, MCF-7 Breast Cancer Cell or Lung Adenocarcinoma A 549 Cell.
The good effect that the present invention has:Osajin chemical combination with anti-tumor activity new in a kind of big fruit banyan is provided Object and preparation method thereof.
Description of the drawings
Fig. 1 is the isoflavone compounds of the present invention1H-NMR is composed(Nuclear magnetic resonance spectroscopy)Figure.
Fig. 2 is the isoflavone compounds of the present invention13C-NMR is composed(Carbon-13 nmr spectra)Figure.
Fig. 3 is the hsqc spectrum figure of the isoflavone compounds element of the present invention.
Fig. 4 is the HMBC spectrograms of the isoflavone compounds of the present invention.
Fig. 5 is the isoflavone compounds of the present invention1H-1H COSY spectrums(Hydrogen hydrogen Correlated Spectroscopy)Figure.
Fig. 6 is the HRESIMS of the isoflavone compounds of the present invention(High-resolution electrospray ionization mass spectrometry)Spectrogram.
Specific implementation mode
Preparation method of the present invention is further illustrated with reference to specific embodiment, but and the scope of the present invention It is not limited to this.
(Embodiment)
The structural formula of the isoflavone compound of the present embodiment such as formula(Ⅰ)It is shown:
(Ⅰ).
The preparation method of the isoflavone compound includes the following steps:
1. the big fruit banyan root grinding and sieving that 20kg is dried in the shade naturally, ethyl alcohol soak extraction 3 at room temperature for being 95% with volume fraction It is secondary, 6 days every time, recycling ethyl alcohol is concentrated under reduced pressure and obtains total medicinal extract 460g, isometric distillation aqueous suspension medicinal extract is added, first uses 3L stones Oily ether extracts 3 times, obtains petroleum ether part medicinal extract 175g, is repeatedly extracted with 3L ethyl acetate until upper solution color is apparent afterwards It is thin out to obtain ethyl acetate extract 70g.
2. by step 1. in ethyl acetate extract 70g petroleum ether-ethyl acetates(100:0-0:100, V/V)Gradient Elution, flow point is collected per 500mL, and the detection of TCL contact plates merges similar compositions and obtains 7 component A-G;Component C is again through petroleum ether- Ethyl acetate (3:1, V/V) column chromatography, the detection of TCL contact plates merge similar compositions and obtain 5 component Fr1-5;
3. by step 2. in Fr3 through efficient liquid phase (methanol/water, 45:55, 3 mL/min, tR=17.6 min) it detaches To 5.6 mg of isoflavones noval chemical compound.
(Test case)
Product analysis is carried out to the isoflavone compound that embodiment obtains:
(1)The isoflavone compounds1H-NMR spectrums are shown in Fig. 1(Solvent acetone-d 6, 400Hz).
(2)The isoflavone compounds13C-NMR spectrums are shown in Fig. 2(Solvent acetone-d 6, 100MHz).
Specific data are shown in Table 1.
Nuclear magnetic resonance data (400/100 MHz, acetone- of 1 Ficaurisoflavone A of tabled 6)
(3)The hsqc spectrum of the isoflavone compounds is shown in Fig. 3(Solvent acetone-d 6).
(4)The HMBC spectrums of the isoflavone compounds are shown in Fig. 4(Solvent acetone-d 6).
(5)The isoflavone compounds1H-1H COSY spectrums(Hydrogen hydrogen Correlated Spectroscopy)See Fig. 5(Solvent acetone-d 6).
(6)The high-resolution electrospray ionization mass spectrometry figure of the isoflavone compounds is shown in Fig. 6.
Isoflavones noval chemical compound:Pale yellow powder is soluble in acetone, methanol; m.p. 157-158 ℃; [α]25 D + 26.5 (c 0.1, CH3OH); UV (CH3OH) λ max (logε): 260 (2.52) nm, 201 (3.56) nm。 It is C that HRESI-MS, which provides the compound molecule formula,20H18O6m/z 355.11771 [M + H]+, calculated value is 355.11761), degree of unsaturation 12.In UV spectrum, there is absorption at 260 nm, illustrate that the compound contains phenyl ring, prompts The compound may be flavone compound.1Low field area provides 1 typical position flavones C-5 and intramolecular carbonyl in H H NMR spectroscopies Base forms the hydroxyl signal of hydrogen bondδ H12.99 (1H, s), 1 positions typical isoflavones C-2 alkene hydrogen signalδ H 8.20 (1H, s), 1 positions C-6 alkene hydrogenδ H6.28 (1H, d, J=2.2 Hz), 1 positions C-8 alkene hydrogenδ H6.42 (1H, d,J=2.2 Hz), 3 group 1, the phenyl ring hydrogen signal of 3,4 substitutionsδ H 7.36 (1H, dd, J = 8.3, 2.2 Hz)、7.30 (1H, d, J=2.2 Hz) and 6.91 (1H, d,J=8.3 Hz), further prove that the compound is osajin Object is closed, in addition,12 cis- alkene hydrogen signals are given in H H NMR spectroscopiesδ H 6.44 (1H, J=9.8 Hz) and 5.77 (1H,J =9.8 Hz), 2 identical methyl signalsδ H1.43 (6H, s);13Provided in C H NMR spectroscopies 1 four substituted benzene ring (δ C 165.5,163.9,159.1,106.1,100.0,94.6), 11,3,4- substituted benzene ring (δ C 154.0, 130.6, 128.0,123.8,122.0,116.8), 1α, βBeta-unsaturated ketone (δ C 181.5,154.5,124.5), information above is being just Meet the skeleton of 15 carbon of isoflavones well, in addition,13Given in C H NMR spectroscopies 2 olefinic carbon signals (δ C 132.0,122.8), 2 A identical methyl carbon signal (δ C 28.3).It can speculate that the compound is the substituted different Huang in the positions C-3' in conjunction with information above Ketone compounds.The connection type of cis-double bonds is determined by HMBC, in HMBC spectrumsδ H 6.44 (1H, J = 9.8 Hz) and 5.77 (1H,J=9.8 Hz) all withδ C 122.0 (C-3') are related, illustrate that double bond is connected to C-3', 2 methylδ H1.43 (6H, s) all withδ C 132.0 (C-2'') are related to 77.2 (C-3''), illustrate that 2 methyl are connected on C-3''. In conclusion the compound is new isoflavone compounds, it is named as:Ficaurisoflavone A.
The structural formula of Ficaurisoflavone A
The HMBC of Ficaurisoflavone A is related
(Test example, anti tumor activity in vitro evaluation)
Test method:The isolated isoflavone compounds of Example carry out antitumor activity.
Tumor cell line:Cervical cancer Hela cells, MCF-7 Breast Cancer Cell, Lung Adenocarcinoma A 549 Cell(University Of Hebei's pharmacy Institute provides).
Positive control:Adriamycin.
Instrument:Refrigerator, autoclave, microplate reader(BioTek ELx800), microscope, freeze drier, CO2Constant temperature trains case, 96 orifice plates, pipettor, electric heating constant-temperature blowing drying box, microstrainer and 0.22 μm of filter membrane, supercentrifuge.
Reagent:RPMI1640 culture solutions, pancreatin, MTT, DMSO, top grade newborn bovine serum.
Specific experiment method:
(1) inoculating cell:With the culture solution containing 10% fetal calf serum(DMEM)It is made into individual cells suspension, with every hole 5 × 104、5 ×105A/mL is inoculated into 96 orifice plates, and per 100 μ L of pore volume, attached cell shifts to an earlier date 12 hours inoculated and cultureds.
(2) testing compound solution is added(40 μ g/mL primary dcreening operations of fixed concentration inhibit growth of tumour cell in the concentration Compound near 50% sets 5 concentration and enters gradient secondary screening, i.e. detectable concentration is respectively 5,1,0.2,0.04,0.008 μ g/ ML is diluted sample to be tested with culture solution)100 μ L, per 100 μ L of hole final volume, each processing is all provided with 3 multiple holes.
(3) it develops the color:After 37 degrees Celsius are cultivated 48 hours, add 20 μ L of MTT solution per hole.Continue to be incubated 4 hours, terminates training It supports, culture supernatant in hole is abandoned in suction, and the DMSO solution of 150 μ L is added per hole, crystal is made fully to melt.
(4) colorimetric:Select 490nm wavelength, microplate reader(BioTek ELx800)Each hole absorbance value is read, result is recorded. Calculate the IC of compound50Value.
Data analysis:
Make ordinate with cell inhibitory rate, the logarithm of concentration is abscissa, makees regression curve, calculates IC50Value.Wherein, inhibit Rate=(Add the OD values of OD values-test group of PBS control group)/ plus PBS control group OD value × 100%.
Test result is as follows for antitumor activity of compound:
2 isoflavone compounds of table inhibit tumor cell proliferation result
AdriamycinaFor positive control.
The result shows that isoflavone compounds all have three kinds of tumor cell proliferations effects of preferable inhibition.

Claims (6)

1. a kind of isoflavones noval chemical compound, structure such as formula(Ⅰ)It is shown:
(Ⅰ).
2. the preparation method of isoflavones noval chemical compound described in claim 1, it is characterised in that include the following steps:
1. with medicinal extract is obtained after alcoholic solution extraction concentration after big fruit banyan tissue nature is dried in the shade, is crushed, medicinal extract adds distillation aqueous suspension Petroleum ether, ethyl acetate extract is obtained by extraction with petroleum ether, ethyl acetate afterwards;
2. 1. ethyl acetate extract that step obtains is obtained 7 component A-G through silica gel column chromatography, component C is again through petroleum ether-second Acetoacetic ester system gradient elution merges similar fraction and obtains 5 component Fr1-5;
3. 2. Fr3 that step is obtained is through the isolated isoflavones noval chemical compound of efficient liquid phase.
3. the preparation method of isoflavones noval chemical compound according to claim 2, it is characterised in that:Above-mentioned steps 1. described in Big fruit banyan be organized as big fruit banyan root, stem, leaf or fruit, alcoholic solution is the ethanol solution that volume fraction is 75%-95%, the steaming Distilled water is 1 with medicinal extract volume ratio:1.
4. the preparation method of isoflavones noval chemical compound according to claim 2, it is characterised in that:Above-mentioned steps 2. center pillar layer It is 100 that analysis eluant, eluent, which is petroleum ether-ethyl acetate volume ratio,:0-0:100.
5. the preparation method of isoflavones noval chemical compound according to claim 2, it is characterised in that:Above-mentioned steps 3. described in Efficient liquid phase dicyandiamide solution is -55% water of 45% methanol.
6. application of the isoflavones noval chemical compound described in claim 1 on inhibiting tumour cell, the tumour cell is uterine neck Cancer Hela cells, MCF-7 Breast Cancer Cell or Lung Adenocarcinoma A 549 Cell.
CN201810022626.0A 2018-01-10 2018-01-10 Isoflavone compound in ficus auriculata as well as preparation method and application thereof Expired - Fee Related CN108358878B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810022626.0A CN108358878B (en) 2018-01-10 2018-01-10 Isoflavone compound in ficus auriculata as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810022626.0A CN108358878B (en) 2018-01-10 2018-01-10 Isoflavone compound in ficus auriculata as well as preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN108358878A true CN108358878A (en) 2018-08-03
CN108358878B CN108358878B (en) 2020-01-21

Family

ID=63011317

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810022626.0A Expired - Fee Related CN108358878B (en) 2018-01-10 2018-01-10 Isoflavone compound in ficus auriculata as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN108358878B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014207069A1 (en) * 2013-06-25 2014-12-31 Universita' Degli Studi Di Siena Multitarget hedgehog pathway inhibitors and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014207069A1 (en) * 2013-06-25 2014-12-31 Universita' Degli Studi Di Siena Multitarget hedgehog pathway inhibitors and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NICOLE DARBOUR ET AL.: ""Isoflavones from Ficus nymphaefolia"", 《NATURAL PRODUCT RESEARCH》 *
STEPHEN S. NYANDORO ET AL.: ""Flavonoids from Erythrina schliebenii"", 《J. NAT. PROD.》 *

Also Published As

Publication number Publication date
CN108358878B (en) 2020-01-21

Similar Documents

Publication Publication Date Title
Nara et al. Novel isoflavone diglycoside in groundnut (Apios americana Medik)
Hou et al. The phenolic constituents and free radical scavenging activities of Gynura formosana Kiamnra
Colombo et al. Farinose alpine Primula species: Phytochemical and morphological investigations
Bello et al. Flavonoids isolated from Vitex grandifolia, an underutilized vegetable, exert monoamine A & B inhibitory and anti-inflammatory effects and their structure-activity relationship
Li et al. Depside derivatives with anti-hepatic fibrosis and anti-diabetic activities from Impatiens balsamina L. flowers
Zuk et al. Temporal biosynthesis of flavone constituents in flax growth stages
Rudrapaul et al. New flavonoids from the fruits of Cornus mas, Cornaceae
Thi et al. Phenylpropanoids from Lilium Asiatic hybrid flowers and their anti-inflammatory activities
Yang et al. Acylphloroglucinol derivatives from the leaves of Syzygium samarangense and their cytotoxic activities
Ngoc et al. A new coumarin and cytotoxic activities of constituents from Cinnamomum cassia
Messi et al. Phenolic compounds from the roots of Ochna schweinfurthiana and their antioxidant and antiplasmodial activities
Wu et al. Bioactive pterocarpans from Trigonella foenum-graecum L
CN105646621B (en) A kind of isoflavone aglycone and preparation method thereof and antiphlogistic use in Juglans Silillata rascal
Alemayehu et al. Phytochemical analysis of the roots of Senna didymobotrya
Jagadeesh et al. Bioactive sterol derivatives isolated from the Pleurotus djamor var. roseus induced apoptosis in cancer cell lines
Yasa et al. Three phenolic glycosides and immunological properties of Achillea millefolium from Iran, population of Golestan
Akramov et al. Phytochemical analysis and biological evaluation of Lagochilus species from Uzbekistan
CN107522706A (en) Parallel double tetrahydrofuran lignans and its preparation method and application
CN108358878A (en) Isoflavones noval chemical compound and its preparation method and application in big fruit banyan
Adekenov Chemical study of Artemisia austriaca Jacq.
Nawwar et al. Three new di-O-glycosyl-C-glucosyl flavones from the leaves of Caesalpinia ferrea Mart.
Lee et al. Phytochemical constituents from the leaves of soybean [Glycine max (L.) Merr.]
El Sissi et al. Plant constituents of Tamarix nilotica leaves (Tamaricaceae)
CN108314669A (en) Isoflavones noval chemical compound and its preparation method and application in big fruit banyan
CN108329287B (en) Compound with epoxy group in ficus auriculata as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200121

CF01 Termination of patent right due to non-payment of annual fee